KARL STORZ United States, a leader in surgical innovation and operating room (OR) integration, announces the US launch of Pathway.AI, a new tool powered by the Artisight Smart Hospital Platform. By de...
Announces New Computer-Vision Technology Designed to Streamline Operations and Eliminate Manual Tasks
EL SEGUNDO, Calif.: KARL STORZ United States, a leader in surgical innovation and operating room (OR) integration, announces the US launch of Pathway.AI, a new tool powered by the Artisight Smart Hospital Platform. By detecting and responding to status changes in the OR, Pathway.AI may help reduce turnover times and eliminate many manual tasks, thereby enhancing OR efficiency and increasing data accuracy.
“Artisight’s expertise in healthcare AI is the perfect complement to KARL STORZ’s proven abilities in transforming the surgical suite,” said Connie Padden, Director, OR1 Technology Integration at KARL STORZ United States. “Bringing the Pathway.AI automation solution to market will allow us both to provide new value to clinicians in the mission-critical OR environment.”
Artisight’s technology uses ambient sensors, microphones, and machine-learning algorithms to monitor and analyze OR workflow activities in real-time. By providing automated capture of operational data, it enables healthcare professionals to streamline processes, prevent delays, and optimize resource utilization. This should result in faster OR turnover, allowing hospitals to potentially accommodate more surgeries and better allocate staff.
“This partnership between Artisight and KARL STORZ represents a pivotal moment in scaling artificial intelligence in healthcare,” said Andrew Gostine, MD, MBA, co-founder and Chief Executive Officer of Artisight. “Too often, great artificial intelligence capabilities fail to achieve broad clinical adoption. By combining Artisight's AI-driven Smart Hospital Platform with KARL STORZ's global prowess in operating room technologies, we're reimagining the entire surgical ecosystem, starting with the delivery of operational efficiencies. Our collaboration will empower healthcare providers with real-time insights and automation, allowing them to focus more on patient care and less on clerical tasks.”
“Pathway.AI can detect when a patient exits the room, when cleaning starts and stops, and when the next patient enters,” said Steve Martin, Director, Corporate Operations, OR1 at KARL STORZ United States. “It can then perform user-defined functions at each of these junctures.” For example, when a patient is wheeled out of the OR, Pathway.AI can automatically send a message to the cleaning staff notifying them that the room is ready for cleaning. At the same time, it can automatically enter a precise timestamp into an electronic medical record (EMR), a task that is typically performed by a busy OR nurse in addition to their patient-care duties.
Pathway.AI is highly customizable and localized to each OR. Localization of the AI algorithm is essential because each institution serves a unique set of patients, and each OR is used for different types of procedures. It allows the system to maximize accuracy and combat model drift and bias. The HIPAA-compliant technology also respects OR sensitivity, applying numerous real-time privacy filters to ensure that all patient and clinician information stays protected.
“Pathway.AI serves as an important step toward a comprehensive, enterprise-wide smart automation solution through the combination of Artisight in patient rooms and clinics and KARL STORZ in the OR,” Martin said. “It’s part of our ongoing effort at KARL STORZ to automate and simplify workflow in the surgical suite as much as possible so that clinicians have more time to spend directly with patients, delivering effective and personalized care—and we're excited to continue that journey with Artisight.”
About KARL STORZ
For nearly 80 years, KARL STORZ has been recognized as a global leader in endoscopic technology and surgical imaging across virtually all surgical specialties. Its integrated OR solutions are designed to enhance collaboration to improve clinical efficiency and outcomes inside the hospital and other sites of care. KARL STORZ is a family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit karlstorz.com.
About Artisight
Artisight redefines the possibilities of healthcare through its Smart Hospital Platform and solutions for virtual care, quality improvement, and care coordination. Artisight's state-of-the-art computer-vision and robust multi-sensor network adapts in real-time to specific environments and workflows, unlocking previously inaccessible data and ensuring seamless integration into the healthcare ecosystem. The Artisight team comprises healthcare leaders with deep clinical expertise who understand the industry’s most pressing challenges. Learn more at artisight.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
#AI--Keysight Technologies, Inc. (NYSE: KEYS) launched AppFusion, a network visibility partner program that integrates third-party security and monitoring…
#AI--AI-powered solutions for addressing visual impairments, optimizing brands for AI search and creating AI agents won the ISG Startup Challenges at…
Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), continues its mission of building smarter, more…
N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”),…